Website Feedback

Use this form to give us your feedback or report any problems you experienced finding information on our Website.

* Indicates Required Fields

Website Feedback

Thank you for providing feedback.

For Financial Investoraccs
 
| |
loading...

Convertible Fund (LACFX) - Class A

Fund Finder

What is the Convertible Fund?

Goal & Strategy

The goal of this Fund is current income and long-term growth of capital through investing in a variety of U.S. and international convertible securities. This Fund seeks to provide income along with the opportunity for equity market participation.

Fund Basics

 
Ticker LACFX
CUSIP 543916753
Fund Number 1404
Inception Date 06/30/2003
YTD Returns at NAV (as of 05/21/2013) 13.42%
Dividend Frequency Quarterly
Expense Ratio (as of 04/30/2013)
Gross 1.13%
Net 1.06%
Lipper Category Avg. 1.18%
Total Net Assets (as of 04/30/2013) $486.34 M
Number of Issues (as of 04/30/2013) 168
Minimum Initial Investment $1,500
Maximum Offering Price (MOP) - Returns with sales charges reflect a maximum sales charge of 2.25%, except for Lord Abbett Bond Debenture Fund 4.75%.
Yield(as of 05/21/2013)
12-Month Dividend Yield Subsidized1 Unsubsidized2
NAV 2.49% 2.42%
MOP 2.44% 2.37%
30-Day Standardized Yield (as of 04/30/2013) 0.94%

Price(as of 05/21/2013)
  Price ($) Change ($) Change (%)
NAV 12.61 0.00 0.00
MOP 12.90 0.00 0.00
52-Week High & Low at NAV ($)
High (05/20/2013) 12.61
Low (06/04/2012) 10.28
In absence of the fee waiver, yields shown would have been lower. Yields for other share classes will vary.

How has the Fund Performed?

Average Annual Returns

(as of 04/30/2013)
  YTD (%) 1-YR (%) 3-YR (%) 5-YR (%) 10-YR (%) Since
Inception (%)
NAV
Lipper Category Avg. 7.98 11.88 7.41 4.43    -    -
Index 9.39 15.47 8.88 6.09    - 6.99
MOP 6.01 10.25 5.91 3.57    - 5.45
Expense Ratio Gross1.13% Net1.06%
  YTD (%) 1-YR (%) 3-YR (%) 5-YR (%) 10-YR (%) Since
Inception (%)
NAV 6.59 9.31 6.51 4.52    - 5.56
Lipper Category Avg. 6.56 8.83 7.49 5.00    -    -
Index 7.59 12.21 9.04 6.82    - 6.87
MOP 4.16 6.81 5.70 4.05    - 5.31
Expense Ratio Gross1.13% Net1.06%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance of future results.

Why This Fund?

Role in Portfolio

A supporting player that provides investors with exposure to fixed income markets along with the potential upside of the equity market, generally with less volatility.

Key Advantages

Experience
Provides investors exposure to an experienced investment management team.

Research
Provides exposure to both equity and fixed income research teams.

The value of your investment will change as interest rates fluctuate and in response to market movements. When interest rates fall, the prices of debt securities tend to rise, and when interest rates rise, the prices of debt securities are likely to decline.

How is the Fund Currently Positioned?

(as of 03/29/2013)
  • The unprecedented accommodation from the Federal Reserve, a stabilizing situation in China, and "open for business" corporate bond markets all support our belief that the U.S. economy will continue its slow-growth trajectory.
  • Accordingly, we continue to position the portfolio in a pro-cyclical manner. On a delta-adjusted basis (which takes into account the equity sensitivity of the holdings), the portfolio is overweight technology, consumer discretionary, and materials relative to the benchmark BofA Merrill Lynch All Convertibles, All Qualities Index.
  • We also are overweight the health care sector relative to the benchmark, with an emphasis on biotechnology companies. The potential for higher demand driven by the Patient Protection and Affordable Care Act and a more accommodative Food and Drug Administration have been broadly positive for this group.
  • The convertible market has shown distinct signs of recovery and the new-issue market has seen broad participation from a number of sectors. According to Barclays, new issuance is running at the highest pace since 2008 and net organic new issuance is also running at a positive for the first time since 2007. In the first quarter of 2013, convertibles captured 72% of the equity market upside, as measured by the S&P 500® Index, and in line with historical levels.
The S&P 500® Index is widely regarded as the standard for measuring large cap U.S. stock market performance and includes a representative sample of leading companies in leading industries.

Average Delta compares the change in the price of the underlying asset to the corresponding change in the price of a derivative.

The Fund's portfolio is actively managed and may change significantly over time.

The credit qualities of securities in the portfolio are assigned by a nationally recognized statistical rating organization (NRSRO), such as Standard & Poor's, Moody's, or Fitch, as an indication of an issuer's creditworthiness. Ratings range from 'AAA' (highest) to 'D' (lowest). Bonds rated 'BBB' or above are considered investment grade. Credit ratings 'BB' and below are lower-rated securities (junk bonds). High-yielding, non-investment-grade bonds (junk bonds) involve higher risks than investment-grade bonds. Adverse conditions may affect the issuer's ability to pay interest and principal on these securities.

RELATED CONTENT

Investment Team

Team Leader
Christopher J. Towle, CFA
Partner
Years Experience:  34
Supported By
20 Investment Professionals
14 Years Avg. Industry Experience
Years experience refers to industry experience.